Recap: CDK Global Q1 Earnings
CDK Global (NASDAQ:CDK) reported its Q1 earnings results on Tuesday, November 2, 2021 at 04:01 PM.
Here's what investors need to know about the announcement.
CDK Global Q1 EPS $0.77 Beats $0.67 Estimate, Sales $440.00M Miss $441.05M Estimate
CDK Global (NASDAQ:CDK) reported quarterly earnings of $0.77 per share which beat the analyst consensus estimate of $0.67 by 14.93 percent. This is a 6.1 percent decrease over earnings of $0.82 per share from the same
CDK Global’s Return On Capital Employed Overview
According to Benzinga Pro, during Q4, CDK Global (NASDAQ:CDK) earned $101.70 million, a 16.37% increase from the preceding quarter. CDK Global's sales decreased to $420.10 million, a 3.0% change since Q3.
Earnings Scheduled For November 2, 2021
Companies Reporting Before The Bell
• Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion.
CDK Global to Acquire Insurance Technology Platform Salty Dot; Terms Not Disclosed
CDK Global, Inc. (NASDAQ:CDK), a leading automotive retail technology company, has entered into a definitive agreement to acquire Salty Dot, Inc. ("Salty"), a convenient, mobile-first solution
Understanding CDK Global’s Ex-Dividend Date
On August 13, 2021, CDK Global (NASDAQ:CDK) announced shareholders can expect to receive a dividend payable on September 30, 2021. The stock will then go ex-dividend 1 business day(s) before the record date. The ex-dividend date for CDK Global will be on August 31, 2021.
Stocks That Hit 52-Week Lows On Monday
Before 10 a.m. ET on Monday, 29 stocks hit new 52-week lows.
46 Biggest Movers From Yesterday
Gainers
PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares climbed 189.5% to close at $9.90 on Wednesday after surging over 15% on Tuesday.
34 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 139% to $8.18 after surging over 15% on Tuesday.